Loading…
Based on limited metadata, this FDA Warning Letter issued to New Spirit Naturals Inc. on May 7, 2020, concerns drug products manufactured or distributed by the company. Without access to the full letter text or specific subject line, the precise nature of the violations cannot be determined, though they fall under FDA's drug regulatory authority. The letter represents a federal enforcement action regarding compliance with drug manufacturing, marketing, or labeling requirements, though the specific issuing office and detailed violation count are not available in this metadata summary.